A detailed history of Clearstead Advisors, LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 22,000 shares of GOSS stock, worth $25,299. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,000
Previous 22,000 -0.0%
Holding current value
$25,299
Previous $21,000 9.52%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$0.96 - $2.92 $17,760 - $54,020
18,500 Added 528.57%
22,000 $27,000
Q4 2020

Feb 11, 2021

BUY
$8.3 - $13.59 $20,750 - $33,975
2,500 Added 250.0%
3,500 $34,000
Q1 2020

May 14, 2020

BUY
$8.0 - $15.48 $8,000 - $15,480
1,000 New
1,000 $10,000

Others Institutions Holding GOSS

About Gossamer Bio, Inc.


  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $108M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Clearstead Advisors, LLC Portfolio

Follow Clearstead Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.